Trial Profile
Effects of rivastigmine on the appetite of patients with Alzheimer's disease (Relationship of BuChE activity and ghrelin level in blood)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Mar 2019
Price :
$35
*
At a glance
- Drugs Rivastigmine (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics; Pharmacokinetics
- 08 May 2018 Status changed from active, no longer recruiting to completed.
- 06 May 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 07 Nov 2014 New trial record